WHO ICTRP trial
Prospective observational study investigating the significance of the epigenetic…
JPRN-UMIN000057914 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000057914 |
|---|---|
| Public title | Prospective observational study investigating the significance of the epigenetic clock in treatment-naive patients with non-small cell lung cancer receiving immune checkpoint blockade therapy |
| Scientific title | Prospective observational study investigating the significance of the epigenetic clock in treatment-naive patients with non-small cell lung cancer receiving immune checkpoint blockade therapy - EpiClock-NSCLC Study |
| Primary sponsor | Hamamatsu University School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Non-small cell lung cancer |
| Registration date | Jul 31, 2025 |
| Target size | 50 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: